Cleveland Clinic Florida launches immuno-oncology and infectious disease-focused innovation center

Cleveland Clinic Florida on July 8 opened the St. Lucie-based Florida Research and Innovation Center, established to facilitate translational research on immuno-oncology and infectious diseases.

Researchers will pilot projects at the center to address local and international health threats, such as pathogens and cancer. They will collaborate with two other Cleveland Clinic centers, the newly launched Center for Global and Emerging Pathogens Research and the Lerner Research Institute's Center for Therapeutics Discovery, to discover new treatments.

Michaela Gack, PhD, serves as the scientific director of the innovation center. She is a virologist whose previous research centers on the immune system's reaction to viral agents.

More articles on digital transformation:
10 big advancements in healthcare tech during the pandemic
Pandemic sped up Mayo's digital transformation by 10 years, Dr. John Halamka says
18 companies in UPMC Enterprises' portfolio

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers